This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Trimeris, Inc.. Active years: 2000-2001.
Company Filing History:
Years Active: 2000-2001
Title: Maynard Lichty: Innovator in Peptide Synthesis
Introduction
Maynard Lichty is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of peptide synthesis, holding a total of 2 patents. His work focuses on innovative methods that enhance the synthesis of peptides, particularly T-20 and T-20-like peptides.
Latest Patents
Lichty's latest patents revolve around methods and compositions for peptide synthesis. The inventions detail procedures for synthesizing peptides, specifically T-20 (also known as "DP-178"; SEQ ID NO:1) and similar peptides. These methods employ both solid and liquid phase synthesis techniques to create and combine specific peptide fragments, ultimately yielding the desired peptide. Additionally, the patents describe individual peptide fragments that serve as intermediates in the synthesis process, as well as groups of these fragments that can be utilized together to produce full-length T-20 and T-20-like peptides.
Career Highlights
Maynard Lichty is associated with Trimeris, Inc., where he continues to advance his research in peptide synthesis. His work has contributed to the understanding and development of peptide-based therapies, showcasing his commitment to innovation in the field.
Collaborations
Lichty has collaborated with notable colleagues, including Brian L Bray and Catherine Mader. These partnerships have likely enriched his research and contributed to the success of his inventions.
Conclusion
Maynard Lichty stands out as an influential inventor in the realm of peptide synthesis, with a focus on developing methods that enhance the production of important therapeutic peptides. His contributions continue to impact the field significantly.